Document:

Exhibit 10.2

 

NOTICE OF OPTION GRANT 

 

You have been granted
the following options (the “Options") to purchase Ordinary Shares par value NIS 0.01 each (the “Shares")
of MedyMatch Technology Ltd. (the “Company"), pursuant and subject to the terms and conditions of the Company’s
2015 Share Incentive Plan, a copy of which is attached hereto as Exhibit A (as may be amended from time to time, the “Plan"),
and the additional terms and conditions contained herein. Unless otherwise defined, capitalized terms used herein shall have
the meaning ascribed to them under the Plan hereof.

 

	Grantee:	 	 
	 	 	 
	Date of Grant:	 	 
	 	 	 
	such date being subject to Section 9.4 of
    the Plan and Section 10.2 of this Agreement 
	 	 	 
	Intended Type of Award: 	 	 	  Incentive Stock
    Option (U.S.)
	(☒
    check one):	 	 	  Nonqualified
    Stock Option (U.S.)
	 	 	 	  Option designated
    as 102 Capital Gains Track Award (with Trustee) (Israel)
	 	 	 	  Option designated
    as 102 Ordinary Income Track Award (with Trustee) (Israel)
	 	 	 	  Option designated
    as 102 Non-Trustee Award (Israel)
	 	 	 	  Option designated
    as 3(9) Award (Israel)
	 	 	 	 
	the above being subject to Section ‎9
    of the Option Agreement, Section 18.4 of the Plan and applicable law
	 	 	 
	Exercise Price 	 	(US$ / NIS / Other)	 	  per Share
	 	 	 
	Number of Shares underlying the Options:	 	 
	 	 	 
	Vesting Commencement Date:	 	 
	 	 	 
	Vesting Schedule:	 	Subject to the terms of
    the Plan (including Sections 6.6 and 6.7 thereof), the Options shall vest and become exercisable under the following schedule:
    25% of the Shares covered by the Options, on the first anniversary of the date on the Vesting Commencement Date, and 6.25%
    of the Shares covered by the Options at the end of each subsequent three-month period thereafter over the course of the subsequent
    3 years; provided, in each case, that the Grantee remains continuously as a Service Provider of the Company or its
    Affiliates throughout each such vesting date.
	 	 	 
	Exercise Period:	 	The date determined in accordance
    with and subject to Section ‎8 of the Option Agreement and the provisions of the Plan
	 	 	 	 	 	 

The Options are governed by this Notice
and by the provisions of the Plan and the Option Agreement, both of which are attached to and made an integral part of this Notice.
By signing the Option Agreement, the Grantee acknowledges receipt of copies of the Plan and the Option Agreement, represents that
the Grantee read and is familiar with their provisions, and hereby accepts the Options subject to all of their terms and conditions.

 

     

     

    

 

THIS OPTION AGREEMENT AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THE OPTIONS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”) OR SUCH APPLICABLE LAWS OF OTHER JURISDICTIONS, OR QUALIFIED UNDER ANY SECURITIES LAW OR ANY OTHER JURISDICTION, AND,
SUBJECT TO THEIR TERMS, MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR SUCH APPLICABLE LAWS OF OTHER JURISDICTIONS COVERING THIS AGREEMENT AND/OR
SUCH SECURITIES, OR THE HOLDER RECEIVES AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY STATING THAT SUCH OFFERING, SALE, TRANSFER,
ASSIGNMENT, PLEDGE OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT
AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE LAW.

 

OPTION AGREEMENT

 

The Company has granted to the Grantee
named in the Notice of Option Grant to which this Option Agreement (this “Agreement") is attached Options upon the
terms and conditions set forth in the Notice and this Agreement. The Options have been granted pursuant to and shall in all respects
be subject to the terms and conditions of the Notice, this Agreement and the Plan, the provisions of which are incorporated herein
by reference and made an integral part of this Agreement.

 

By signing this Agreement, the Grantee:
(a) represents that the Grantee has received copies of, and has read and is familiar with the terms and conditions of, the Notice,
the Plan and this Agreement, (b) accepts the Options, the Shares issued upon the exercise thereof and/or any securities issued
or distributed with respect thereto are subject to all of the terms and conditions of the Notice, the Plan this Agreement, the
Trust Agreement and any other documents ancillary hereto or thereto, and (c) agrees to accept as binding, conclusive and final
all decisions and interpretations of the Board or the Committee upon any questions arising under the Notice, the Plan or this
Agreement (whether before or after the issuance of Shares pursuant to the Options). While certain terms and conditions
are included in this Agreement, such terms and conditions shall not in any way derogate from the applicability of all other terms
and conditions set forth in the Plan. The Grantee acknowledges that the terms and conditions of the Plan may be amended from time
to time as set forth therein, and therefore, any reference to the Plan shall be deemed to refer to the Plan as amended from time
to time, including any amendments adopted after the date of grant. Unless otherwise stated, in the event of any inconsistency
or contradiction between any of the terms of this Agreement and the provisions of the Plan, the terms and provisions of this Agreement
shall prevail.

 

1. No Disposition
of Options. The Options shall not be sold, pledged or otherwise transferred (whether by operation of law or otherwise),
and shall not be subject to sale under execution, attachment, levy or similar process (each of the foregoing, a “Transfer")
other than by will or by the laws of descent and distribution.

 

2. Issuance and
Disposition of Shares.

 

2.1. Legal Compliance.
The Company shall have no obligations to issue Shares pursuant to the exercise or settlement of Options and Options may not be
exercised or settled (even if vested), if the issuance of Shares upon exercise or settlement would constitute a violation of any
Applicable Laws as determined by the Company, including, applicable federal, state or foreign securities laws or other law or
regulations or the requirements of any stock exchange or market system upon which the Shares may then be listed. THE GRANTEE IS
CAUTIONED THAT THE OPTIONS MAY NOT BE EXERCISED UNLESS THE FOREGOING CONDITIONS AND THOSE SET FORTH IN THE PLAN ARE SATISFIED.
ACCORDINGLY, THE OPTIONEE MAY NOT BE ABLE TO EXERCISE THE OPTIONS WHEN DESIRED EVEN THOUGH THE OPTION IS VESTED.

 

    	 	- 2 -	 

     

    

 

2.2. Provisions
Governing Shares. Shares issued upon exercise of Options shall be subject to the restrictions referred to in Section 16 of
the Plan (Conditions upon Issuance of Shares; Governing Provisions) and in this Agreement, the Articles of Association of the
Company, any limitation, restriction or obligation included in any shareholders agreement applicable to all or substantially all
of the holders of Shares (regardless of whether or not the Grantee is a formal party to such shareholders agreement), any other
governing documents of the Company, and all policies, manuals and internal regulations adopted by the Company from time to time,
in each case, as may be amended from time to time, including, without limitation, any provisions included therein concerning restrictions
or limitations on disposition of Shares (such as, but not limited to, right of first refusal and lock-up/market stand-off) or
grant of any rights with respect thereto, forced sale and bring along provisions, any provisions concerning a restrictions on
the use of inside information and other provisions deemed by the Company to be appropriate in order to ensure compliance with
Applicable Laws and with the requirements of any transaction entered into or proposed to be entered into by the Company. By exercising
an Option the Grantee is deemed to have undertaken to comply with all the foregoing provisions. Each Grantee shall execute such
separate agreement(s) as may be requested by the Company relating to matters set forth in this Section ‎2. The execution of
such separate agreement(s) may be a condition by the Company to the exercise of any Options.

 

2.3. Forced Sale.
In the event the that Board approves a Merger/Sale effected by way of a forced or compulsory sale (whether pursuant to the Company’s
Articles of Association or pursuant to Section 341 of the Companies Law), then, without derogating from such provisions and in
addition thereto, the Grantee agrees to the offer to effect the Merger/Sale on the terms approved by the Board (and that the Shares
held by or for the benefit of the Grantee shall be included in the shares of the Company approving the terms of such Merger/Sale
for the purpose of satisfying the required majority), and to sell all of the Shares held by or for the benefit of the Grantee
on the terms and conditions applying to the holders of Shares, in accordance with the instructions then issued by the Board, whose
determination shall be final. The Grantee agrees not contest, bring any claims or demands, or exercise any appraisal rights related
to any of the foregoing. The proxy pursuant to this Agreement includes an authorization of the proxy holder to sign, by and on
behalf of any Grantee, such documents and agreements as are required to affect the sale of Shares in connection with such Merger/Sale.

 

2.4. Waiver.
As a material precondition to the Company’s grant of Option and issuance of any Shares under the Plan, the Grantee hereby
irrevocably waives any right of first refusal, pre-emptive, co-sale, participation rights or other similar rights with respect
to any prior or future Transfer of any shares in the Company by other shareholder or the issuance of securities by the Company,
if such right was so provided in any agreement between the Company and any of its shareholders, in the Articles of Association
or in any other governing document of the Company. The Grantee acknowledges and agrees that the Company and its shareholders are
entitled to rely on this irrevocable waiver.

 

2.5. Additional
or Substituted Securities. In the event that in connection with the declaration of a share dividend (bonus shares),
a share split, a reverse share split, a reorganization (which may include a combination or exchange of shares), a consolidation,
a spin-off or other corporate divestiture or division, a recapitalization, a reclassification or other similar occurrence affecting
the Company’s outstanding securities without receipt of consideration (or in consideration for the par value), any new,
substituted or additional securities or other property (other than cash dividend) are distributed by reason of such occurrence
with respect to any Shares which are subject to this Section ‎2, or into which such Shares thereby become convertible, then
such substituted or additional securities or other property (if distributed) shall immediately be subject to this Section ‎2.
Any adjustments to reflect the distribution of such securities or other property shall be conclusively determined by the Company.
The terms and conditions contained herein and in the Plan in respect of the Option and/or the Shares shall apply to any new, substituted
or additional securities or other property resulting from the above adjustments.

 

2.6. Market Stand-Off.
As a material precondition to the grant of Options and the issuance of any Shares in accordance with the Plan, and without
limitation of Section 17 of the Plan, the Grantee hereby executes a market stand-off undertaking in the form attached hereto as
Exhibit B.

 

2.7. Board Approval.
Any Transfer or other disposition of Shares or any interest therein is subject to the prior approval of the Board, which, if granted
(without any obligation to do so), may be subject to such terms, conditions and restrictions, as it deems appropriate. The terms,
conditions and restrictions of any approval may differ from one Grantee to another, and need not be the same. Any Transfer or
otherwise grant of any interest in any Shares to any third party that does not comply with this Section shall be null and void
and shall not confer upon any person, other than the Grantee, any rights. This provision shall terminate immediately prior to,
and such termination is conditioned upon, the IPO. This Section shall apply in addition to any other limitation, restriction and/or
condition in the Plan or this Agreement (including, without limitation, after the application of Section 16 of the Plan), any
shareholders agreement, Company’s charter documents or other instrument between the Grantee and the Company or by which
the Grantee is bound. This Section shall not apply to a transfer of Shares in a Merger/Sale.

 

    	 	- 3 -	 

     

    

 

3. Exercise Procedures.

 

3.1. The Grantee
may exercise Options that have become exercisable by giving a signed written notice to the Company, delivered in person or by
mail (or such other methods of delivery prescribed by the Company) to the Chief Financial Officer of the Company or to such other
person as determined by the Committee, or in any other manner as the Committee shall prescribe from time to time. The exercise
notice shall be in a form prescribed by the Company from time to time. The Grantee shall specify in the notice the election to
exercise Options, the number of Shares for which it is being exercised (which may be equal to or lower than the aggregate number
of Shares that have become exercisable at such time, subject to the last sentence of this Section), accompanied by payment of
the aggregate Exercise Price for such Shares in the manner permitted by the Plan. In the event that Options are being exercised
by the representative of the Grantee, if permitted under the Plan, the notice shall be accompanied by proof (satisfactory to the
Company) of the representative’s right to exercise such Options. [For as long as the Company’s shares are not listed
for trading on any securities exchange or over-the-counter market and unless the Committee determines otherwise, a Grantee may
not exercise Options unless the aggregate Exercise Price thereof is equal to or in excess of the lower of: (a) the aggregate Exercise
Price for all Shares as to which the Options has become exercisable at such time; or (b) US$[2,000].]

 

3.2. After receiving
a proper and duly executed notice of exercise in the form prescribed by the Company, the Company shall cause to be issued a certificate
or certificates for the Shares as to which the Options have been exercised, registered in the name of the person exercising such
Options, except that in case of Options designated as 102 Trustee Awards, the Shares shall be issued to and in the name of the
Trustee for the benefit of the Grantee. The issuance shall be subject to the payment of any and all applicable taxes and compulsory
payments by the Grantee. Subject to Section 19 of the Plan, the Grantee shall have no rights as a shareholder with respect to
any Shares subject to Options until the Grantee shall have duly exercised the Options, paid the full Exercise Price therefor,
if required, paid all applicable taxes and compulsory payments therefor and becomes the record holder of the subject Shares.

 

3.3. Without derogating
from the provision of the Plan, in the event that the Company or, with respect to 102 Trustee Awards, the Trustee, determines
that it is required to withhold any tax as a result of the exercise of Options, the Grantee, as a condition to the exercise of
Options, shall make arrangements satisfactory to the Company and the Trustee, if applicable, to enable it to satisfy all withholding
requirements. The Grantee shall also make arrangements satisfactory to the Company and the Trustee, if applicable, to enable it
to satisfy any withholding requirements that may arise in connection with the vesting or disposition of Shares acquired pursuant
to the grant of an Option under the Plan. Furthermore, the Grantee shall indemnify the Company and the Trustee, if applicable,
and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without
limitation, liabilities relating to withholding.

 

4. Payment of
Exercise Price. The Exercise Price shall be paid in cash or in such other manner as determined in accordance with the
Plan.

 

5. Irrevocable
Proxy. As a material precondition to the Company’s grant of Options and issuance of Shares in accordance with the
Plan, the Grantee hereby executes an irrevocable proxy in the form attached hereto as Exhibit C (and, if applicable,
instructs the Trustee to sign such proxy, as requested by the Company), to the Company which shall designate such person or persons
(with a right of substitution) from time to time as determined by the Committee (and in the absence of such determination, the
CEO or Chairman of the Board, ex officio). The provisions of this Section shall apply to the Grantee and to any purchaser, assignee
or transferee of any Shares.

 

6. Repurchase
Right. Grantee agrees that all Shares issued pursuant to the exercise of the Option shall be subject to certain repurchase
rights in favor of the Company or its assigns as provided in the Plan.

 

    	 	- 4 -	 

     

    

 

7. Legend.
The Company may at any time place legends referencing the restriction imposed on the Shares (including, without limitation, right
of first refusal and right of repurchase) and any applicable federal, state or foreign securities law restrictions on all certificates
representing Shares subject to the provisions of this Agreement. The Grantee shall, at the request of the Company, promptly present
to the Company any and all certificates representing Shares acquired pursuant to Options in the possession of the Grantee in order
to carry out the provisions of this Section. Unless otherwise specified by the Company, legends placed on such certificates may
include, but shall not be limited to, the following:

 

7.1. THIS SECURITIES
EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)
OR SUCH APPLICABLE LAWS OF OTHER JURISDICTIONS, OR QUALIFIED UNDER ANY SECURITIES LAW OR ANY OTHER JURISDICTION, AND, SUBJECT
TO THEIR TERMS, MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR SUCH APPLICABLE LAWS OF OTHER JURISDICTIONS COVERING SUCH SECURITIES, OR THE COMPANY RECEIVES
AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY, STATING THAT SUCH OFFERING, SALE, TRANSFER, ASSIGNMENT, PLEDGE OR HYPOTHECATION
IS EXEMPT FROM THE REGISTRATION OR PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT OR THE QUALIFICATION REQUIREMENTS UNDER
APPLICABLE LAW.

 

7.2. THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO THE COMPANY’S ARTICLES OF ASSOCIATION, THE COMPANY’S SHARE INCENTIVE PLAN AND THE
OPTION AGREEMENT WITH THE COMPANY, EACH AS AMENDED FROM TIME TO TIME, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THIS
COMPANY.

 

8. Term and Expiration.
The Options shall expire in accordance with the Plan, including in case the Grantee’s employment or service terminates for
any reason.

 

9. Tax Matters and
Consultation.

 

9.1. THE GRANTEE
IS ADVISED TO CONSULT WITH A TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES OF RECEIVING OR EXERCISING OPTIONS HEREUNDER. THE
COMPANY DOES NOT ASSUME ANY RESPONSIBILITY TO ADVISE THE GRANTEE ON SUCH MATTERS, WHICH SHALL REMAIN SOLELY THE RESPONSIBILITY
OF THE GRANTEE. Without derogating from Section 18 of the Plan, and notwithstanding anything to the contrary, including the indication
under “Type of Award” above, the Company shall be under no duty to ensure, and no representation or commitment is
made, that the Option qualifies or will qualify under any particular tax treatment (such as Section 102, ISO or any other treatment),
nor shall the Company be required to take any action for the qualification of any Option under such tax treatment. If the Options
do not qualify under any particular tax treatment it could result in adverse tax consequences to the Grantee. By signing below,
Grantee agrees that the Company and its Affiliates and their respective employees, directors, officers and shareholders shall
not be liable for any tax, penalty, interest or cost incurred by Grantee as a result of such determination, nor will any of them
have any liability of any kind or nature in the event that, for any reason whatsoever, an Option does not qualify for any particular
tax treatment.

 

9.2. Without limitation
of the foregoing, with respect to Incentive Stock Option and Nonqualified Stock Option, there is no guarantee that the Internal
Revenue Service ("IRS") will determine that the Exercise Price of these Option represent the fair market value thereof
as of the Date of Grant in compliance with the requirements of Section 409A of the Code. If the IRS determines that the Exercise
Price is less than such fair market value it could result in adverse tax consequences to Grantee.

 

9.3. In case of Incentive
Stock Options, adjustments made pursuant to the Plan with respect to Incentive Stock Options could constitute a “modification”
of such Incentive Stock Options (as that term is defined in Section 424(h) of the Code) or could cause adverse tax consequences
for the Grantee and the Grantee should consult with his or her tax advisor regarding the consequences of such “modification”
on his or her income tax treatment with respect to the Incentive Stock Option.

 

10. Section 102 Awards.

 

10.1. Eligibility
for Awards. Subject to Applicable Law, 102 Awards may only be granted to an “employee” within the meaning of Section
102(a) of the Ordinance (which as of the date hereof means (i) individuals employed by an Israeli company being the Company or
any of its Affiliates, and (ii) individuals who are serving and are engaged personally (and not through an entity) as “office
holders” by such an Israeli company), but may not be granted to a Controlling Stockholder ("Eligible 102 Grantees").
Eligible 102 Grantees may receive only 102 Awards, which may either be granted to a Trustee or granted under Section 102 of the
Ordinance without a Trustee.

 

    	 	- 5 -	 

     

    

 

10.2. 102 Award
Grant Date.

 

10.2.1. Each 102 Award
will be deemed granted on the date determined by the Committee, subject to Section ‎10.2.2, provided that (i) the Grantee
has signed all documents required by the Company or pursuant to Applicable Law, and (ii) with respect to 102 Trustee Awards, the
Company has provided all applicable documents to the Trustee in accordance with the guidelines published by the ITA, and if this
Agreement is not signed and delivered by the Grantee within 90 days from the date determined by the Committee (subject to Section
‎10.2.2), then such 102 Trustee Award shall be deemed granted on such later date as this Agreement is signed and delivered
and on which the Company has provided all applicable documents to the Trustee in accordance with the guidelines published by the
ITA. In the case of any contradiction, this provision and the date of grant determined pursuant hereto shall supersede and be
deemed to amend any date of grant indicated in the Notice of Option Grant or in any corporate resolution or any agreement.

 

10.2.2. Unless otherwise
permitted by the Ordinance, any grants of 102 Trustee Awards that are made on or after the date of the adoption of this Plan or
an amendment to this Plan, as the case may be, that may become effective only at the expiration of thirty (30) days after the
filing of this Plan or any amendment thereof (as the case may be) with the ITA in accordance with the Ordinance shall be conditional
upon the expiration of such 30-day period, such condition shall be read and is incorporated by reference into any corporate resolutions
approving such grants and into this Agreement and any agreement evidencing such grants (whether or not explicitly referring to
such condition), and the date of grant shall be at the expiration of such 30-day period, whether or not the date of grant indicated
therein corresponds with this Section. In the case of any contradiction, this provision and the date of grant determined pursuant
hereto shall supersede and be deemed to amend any date of grant indicated in the Notice of Option Grant or in any corporate resolution
or any agreement.

 

10.3. To the extent
and with respect to 102 Trustee Awards, the Grantee acknowledges, undertakes and confirms that: (i) the Grantee fully understands
that Section 102 Ordinance and the rules and regulations enacted thereunder apply to the Options, and (ii) the Grantee understands
the provisions of Section 102 of the Ordinance, the tax track chosen thereunder and the implications thereof. If applicable, the
terms of such Options shall also be subject to the terms of the Trust Agreement made between the Company and the Trustee for the
benefit of the Grantee, and the Grantee shall sign all documents requested by the Company or the Trustee, in accordance with and
under the trust agreement. A copy of the trust agreement is available for the Grantee’s review, during normal working
hours, at the Company’s offices.

 

10.4. Grantee
Undertaking. Without derogating from the generality of the foregoing, to the extent and with respect to any Options that are
102 Capital Gain Track Awards, and as required by Section 102 of the Ordinance and the Rules, the Grantee acknowledges, undertakes
and confirms in writing the following (which shall be apply and relate to all Awards granted to the Grantee, whether under this
Plan or other plans maintained by the Company, and whether prior to or after the date hereof, if any):

 

10.4.1. The Grantee
shall comply with all terms and conditions set forth in Section 102 of the Ordinance with regard to the “Capital Gain Track”
and the applicable rules and regulations promulgated thereunder, as amended from time to time;

 

10.4.2. The Grantee
is familiar with, and understands the provisions of, Section 102 of the Ordinance in general, and the tax arrangement under the
“Capital Gain Track” in particular, and its tax consequences; the Grantee agrees that the Options and Shares that
may be issued upon exercise of the Options (or otherwise in relation to the Options), will be held by a trustee appointed pursuant
to Section 102 of the Ordinance for at least the duration of the Holding Period, as defined in Section 102 under the “Capital
Gain Track”. The Grantee understands that any release of such Options or Shares from trust, or any sale of the Share prior
to the termination of the Holding Period, will result in taxation at marginal tax rates, in addition to deductions of appropriate
social security, health tax contributions or other compulsory payments; and

 

    	 	- 6 -	 

     

    

 

10.4.3. The Grantee
agrees to the trust agreement signed between the Company, his employing company and the trustee appointed pursuant to Section
102 of the Ordinance and shall sign all documents requested by the Company or the Trustee, in accordance with and under the trust
agreement.

 

11. Plan
Termination or Amendment. The Board may terminate or amend the Plan or the Option at any time, subject to the Plan
and any such amendment shall apply on the Grantee and this Option Agreement (including the Options and Shares issuable or issued
pursuant thereto), without any required consent of the Grantee. Except as set forth above, this Agreement shall not be amended
without the consent of the parties hereto.

 

12. Miscellaneous.

 

12.1. Further
Assurances. The Grantee shall perform such further acts and execute such further documents as may reasonably be necessary
by the Company to carry out and give full effect to the provisions of this Agreement and the Plan.

 

12.2. Fractional
Shares. No fractional Share shall be issuable upon exercise or vesting of any Options and the number of Shares to be issued
shall be rounded down to the nearest whole Share, with in any Share remaining at the last vesting date due to such rounding to
be issued upon exercise at such last vesting date.

 

12.3. Entire Agreement.
This Agreement (together with the Notice and all Exhibits) and the Plan constitutes the full and entire understanding and agreement
between the parties with regard to the subject matters hereof and thereof, and supersede all prior agreements and understandings,
both written and oral (with no concession being made as to the existence of any such agreements and understandings).

 

12.4. Governing
Law; Jurisdiction. This Agreement shall be governed by and construed according to the laws of the State of Israel, without
regard to the conflict of law provisions thereof. Any dispute arising under or proceeding in relation to this Agreement shall
be resolved exclusively in the competent court in Tel Aviv-Jaffa, and each of the parties hereby irrevocably submits to the exclusive
jurisdiction of such court.

 

12.5. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and enforceable against
the parties, and all of which together shall be considered one and the same agreement, it being understood that all parties need
not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by facsimile transmission,
electronic transmission or electronic signature shall be sufficient to bind the parties to the terms and conditions of this Agreement,
as an original.

 

- Signature Pages
Following -

 

    	 	- 7 -	 

     

    

 

IN WITNESS WHEREOF,
the parties have duly executed and delivered this OPTION AGREEMENT as of the date last written below.

 

	Grantee:	 	MEDYMATCH TECHNOLOGY LTD.
	 	 	 	 	 
	Name:	                           	 	Name:	                          
	ID no.:	 	 	Title:	 
	Date:	 	 	Date:	 

 

     

     

    

 

EXHIBIT A

 

THE PLAN

as of
the date hereof, subject to further amendments

 

    A- 1 

     

    

 

EXHIBIT B

 

Market Stand-Off Undertaking

 

To:

MedyMatch
Technology Ltd. (the “Company"); and

The
underwriters of the Company’s public offering

 

Dear
Sirs:

 

In connection with
any underwritten public offering of equity securities of the Company pursuant to an effective registration statement filed under
the U.S. Securities Act of 1933, as amended, or equivalent law in another jurisdiction, and in recognition of the benefit that
such an offering will confer upon the undersigned as a shareholder of the Company, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with the Company and each underwriter, during
the Lock Up Period (as defined below), that the undersigned will not, without the prior written consent of the Company or the
underwriters (or the lead underwriter, as the underwriters shall agree among themselves), directly or indirectly, (i) lend, offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant for the sale of, or otherwise dispose of or transfer any shares or any securities convertible into or exchangeable
or exercisable for shares or securities of the Company, whether now owned or hereafter acquired by the undersigned or with respect
to which the undersigned has or hereafter acquires the power of disposition (including, without limitation, Awards under any Company
share or equity plan) and any shares or other securities issued or distributed with respect to or in substitution of any of the
foregoing (collectively, the “Lock Up Securities"), (ii) exercise any right with respect to the registration
of any of the Lock Up Securities, or file or cause to be filed any registration statement in connection therewith, under the U.S.
Securities Act of 1933, as amended, or equivalent law in another jurisdiction, or (iii) enter into any swap or any other agreement
or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Lock
Up Securities, whether any such swap or transaction in this clause (iii) or (i) above is to be settled by delivery of shares or
other securities of the Company, in cash or otherwise. The foregoing provisions shall not apply to the sale of any shares to an
underwriter pursuant to an underwriting agreement.

 

The restrictions contained
in this letter shall be in effect for such period of time (the “Lock Up Period"): (A) following the first
public filing of the registration statement relating to the underwritten public offering until the extirpation of 180 days following
the effective date of such registration statement relating to the Company’s initial public offering or 90 days following
the effective date of such registration statement relating to any other public offering; in each case, provided, however, that
if (1) during the last 17 days of the initial Lock Up Period, the Company releases earnings results or announces material news
or a material event or (2) prior to the expiration of the initial Lock Up Period, the Company announces that it will release earnings
results during the 15-day period following the last day of the initial Lock Up Period, then in each case the Lock Up Period will
be automatically extended until the expiration of the 18-day period beginning on the date of release of the earnings results or
the announcement of the material news or material event; or (B) as shall be requested by the Company or the underwriter(s). Notwithstanding
anything herein to the contrary, if the underwriter(s) and the Company agreed on a termination date of the Lock Up Period in the
event of failure to consummation a certain public offering, then such termination shall apply also to the Lock Up Period hereunder
with respect to that particular public offering.

 

In the event of a
subdivision of the outstanding share capital of the Company, the distribution of any securities (whether or not of the Company),
whether as bonus shares or otherwise, and whether as dividend or otherwise, a recapitalization, a reorganization (which may include
a combination or exchange of shares or a similar transaction affecting the Company’s outstanding securities without receipt
of consideration), a consolidation, a spin-off or other corporate divestiture or division, a reclassification or other similar
occurrence, any new, substituted or additional securities which are by reason of such transaction distributed with respect to
any Lock Up Securities, or into which such Lock Up Securities thereby become convertible, shall immediately be subject to the
provisions and restrictions contained herein.

 

    B- 1 

     

    

 

EXHIBIT B

 

The undersigned agrees
that, prior to engaging in any transaction or taking any other action that is subject to the terms of this letter during the Lock
Up Period, it will give notice thereof to the Company and will not consummate such transaction or take any such action unless
it has received written confirmation from the Company that the Lock Up Period has expired.

 

The Company may impose
and the undersigned agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and
registrar against the transfer of the Lock Up Securities except in compliance with the foregoing restrictions.

 

The undersigned understands
that the Company and the underwriters are relying upon this letter in proceeding toward consummation of the offering. The underwriters
in connection with a registration statement so filed are intended third party beneficiaries of this letter and shall have the
right, power and authority to enforce the provisions hereof as though they were a party hereto. The undersigned shall execute
(and hereby empowers the Company as its proxy and attorney-in-fact to do so in his/her name) such separate agreement(s) as may
be requested by the Company or the underwriters in connection with such registration statement and in the form required by them
(which need not be identical to the provisions of this letter, and may include such additional provisions and restrictions as
the underwriter(s) deem advisable) or that are necessary to give further effect thereto. The execution of such separate agreement(s)
may be a condition by the Company to the exercise of any Award under the Company’s share incentive plan(s).

 

This letter is irrevocable
and shall be binding upon the undersigned’s heirs, legal representatives, successors, assigns, and the purchaser or transferee
of any Lock Up Securities. The Company, may, at its discretion, and without any further consent, release or remove some or all
of the restrictions contained in this letter, or allow certain exceptions to such restrictions (whether in general or in any specific
case, and such relief or exceptions need not be the same or identical among to all persons bound by them).

 

This letter shall
not derogate from any provision or restriction contained in any Company’s share incentive plan(s), agreement between the
undersigned the Company or the underwriters, or any restriction or limitation pursuant to applicable law.

 

	 	Very truly yours,
	 	 	 
	 	Signature:	                           
	 	 	 
	 	Print Name:	 
	 	 	 
	 	Date:	 

 

    B- 2 

     

    

 

EXHIBIT C

 

MEDYMATCH TECHNOLOGY LTD. 

(the “Company")

 

irrevocable
Proxy and power of attorney

 

Unless otherwise defined, capitalized
terms used herein shall have the meaning ascribed to them under the Company’s Share Incentive Plan and are incorporated
herein by reference.

 

I, the undersigned,
hereby irrevocably appoints the Company, which shall designate such person or persons as determined by the Committee (and in the
absence of such determination, the CEO or Chairman of the Board of Directors of the Company, ex officio), with full power of substitution,
as my proxy and attorney-in-fact to: (i) cause any number of shares, of any class, of the Company owned by me or by the Trustee
for my benefit, under the Plan or any other share incentive or option plan of the Company, and any other shares or securities
issued or distributed in respect thereto or in substitution or exchange thereof, at any time and from time to time, and as may
be adjusted (collectively, the “Shares"), to be counted as present at any and all Shareholders Meetings (as defined
below); (ii) represent me and to vote in my name at any and all Shareholders Meetings in respect of the Shares; (iii) sign and
execute on my behalf any written resolutions or consents in lieu of a Shareholder Meeting or any other consent, in respect of
the Shares; (iv) exercise or fail to exercise, in the proxyholder’s sole and absolute discretion, any rights or obligations
attached to any and all Shares, and sign on my behalf any document or instrument relating to such rights or obligations, including,
without limitation, shareholders agreements, documents concerning rights of bring along, tag along, first refusal, preemptive
rights, co-sale rights, information rights, registration rights, lock-up/market stand-off and any other rights or obligations,
if any, whether included in the incorporation documents of the Company or any other document or instrument as shall be from time
to time (which exercise may impose on the undersigned monetary liability in connection with a Merger/Sale); and (v) agree to the
offer to effect a Merger/Sale on the terms approved by the Board (and the Shares held by me or for my benefit shall be included
in the shares of the Company approving the terms of such Merger/Sale for the purpose of satisfying any required majority), sell
all of the Shares held by me or for my benefit, in accordance with the instructions then issued by the Board, whose determination
shall be final, and sign on my behalf any document or instrument relating thereto, including, without limitation, share transfer
documents, as are required to affect a compulsory sale of Shares in connection with a Merger/Sale pursuant to the Plan; (vi) receive
all notices and communications with respect to the above, including, without limitation, notices of any Shareholders Meeting (including
any adjournment or postponement thereof) or any written resolution or consent in lieu thereof. “Shareholders Meetings"
shall mean any meeting of the shareholders of the Company, however called, whether an extraordinary or annual meeting and whether
of the share capital as one class or of any class thereof, and including any adjournment or postponement thereof), or any act
or consent of shareholders of the Company (whether of the share capital as one class or of any class thereof) under the Company’s
Articles of Association or otherwise.

 

This proxy and power
of attorney shall be exercised in accordance with the Plan, including, without limitation, Section 6.10 thereof. In any Shareholders
Meeting or written consent in lieu thereof, the Shares shall be voted by the proxy holder, unless directed otherwise by the Board,
in the same proportion as the result of the vote at the Shareholders Meeting in respect of which the Shares are being voted, and
in any act or consent of shareholders under the Company’s Articles of Association or otherwise, such Shares shall be cast
by the proxy holder, unless directed otherwise by the Board, in the same proportion as the result of the shareholders’ act
or consent.

 

As long as this proxy
and power of attorney is in effect, any and all voting rights I may have with respect to the Shares shall be exercised exclusively
by this proxy and power of attorney. The undersigned hereby revokes any proxy(ies) and power of attorney heretofore given in respect
of the Shares to any person(s) and agrees not to give any other proxies or and power of attorney in derogation or preventing the
undersigned from complying with its obligations hereof, until such time as this proxy is no longer in full force and effect. The
undersigned acknowledges and agrees that this proxy shall be irrevocable and is a special power of attorney coupled with an interest
sufficient in law to support an irrevocable power and shall survive the bankruptcy, death, adjudication of incompetence or the
like of undersigned. This proxy and power of attorney shall survive the transfer of Shares, until duly replaced by a similar power
and power of attorney executed by the transferee. The Company is an intended third party beneficiary of this proxy and power of
attorney. Any person holding or exercising such voting proxies is doing so solely in his/her capacity as the proxy holder and
not individually. This proxy shall terminate and be of no further force and effect immediately after the listing for trading on
a stock exchange or market or trading system of shares of the Company or of the Successor Corporation (as such term is defined
in the Plan).

 

    C- 1 

     

    

 

EXHIBIT C

 

IN WITNESS WHEREOF,
the undersigned has executed this IRREVOCABLE PROXY as of the date written below.

 

	 	Signature:	 
	 	Printed Name: 	 
	 	ID number:	 
	 	Date:	 

 

 

C-2Exhibit
10.3

 

indemnification
agreement

 

THIS
INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of ________ ___, 2018, is entered into by and between
MaxQ AI Ltd., an Israeli company whose address is 76 Yigal Alon St., Tel Aviv-Yafo, 6706701, Israel (the “Company”),
and the undersigned Director or Officer of the Company whose name appears on the signature page hereto officer (the “Indemnitee”).

 

	WHEREAS,	Indemnitee
                                         is an Office Holder (“Nosse Misra”), as such term is defined in the
                                         Companies Law, 5759–1999, as amended (the “Companies
                                         Law” and “Office Holder”
                                         respectively), of the Company; 
	 	 

	WHEREAS,	both
                                         the Company and Indemnitee recognize the increased risk of litigation and other claims
                                         being asserted against Office Holders of companies and that highly competent persons
                                         have become more reluctant to serve corporations as directors and officers or in other
                                         capacities unless they are provided with adequate protection through insurance or adequate
                                         indemnification against inordinate risks of claims and actions against them arising out
                                         of their service to, and activities on behalf of, companies; 
	 	 

	WHEREAS,	the
                                         Articles of Association of the Company authorize the Company to indemnify and advance
                                         expenses to its Office Holders and provide for insurance and exculpation to its Office
                                         Holders, in each case, to the fullest extent permitted by applicable law and this Agreement
                                         is provided to Indemnitee in accordance with applicable law, the Articles of the Association
                                         of the Company and all requisite corporate approvals; 
	 	 

	WHEREAS,	the
                                         Company has determined that (i) the increased difficulty in attracting and retaining
                                         competent persons is detrimental to the best interests of the Company’s shareholders
                                         and that the Company should act to assure such persons that there will be increased certainty
                                         of such protection in the future, (ii) and it is reasonable, prudent and necessary for
                                         the Company contractually to obligate itself to indemnify, and to advance expenses on
                                         behalf of, such persons to the fullest extent permitted by applicable law, so that they
                                         will serve or continue to serve the Company free from undue concern that they will not
                                         be so indemnified;
	 	 

	WHEREAS,	the
                                         Company acknowledges that Indemnitee is relying on the obligations of the Company set
                                         forth in this Agreement in agreeing to serve the Company, which obligations are therefore
                                         irrevocable; and
	 	 

	WHEREAS,	in
                                         recognition of Indemnitee’s need for substantial protection against loss arising
                                         from the Indemnitee’s liability, including costs and expenses incurred by the Indemnitee
                                         due to his position as an Office Holder, in order to assure Indemnitee’s continued
                                         service to the Company in an effective manner and, in part, in order to provide Indemnitee
                                         with specific contractual assurance that the indemnification, insurance and exculpation
                                         afforded by the Articles of Association will be available to Indemnitee, the Company
                                         wishes to undertake in this Agreement for the indemnification of and the advancing of
                                         expenses to Indemnitee to the fullest extent permitted by applicable law and as set forth
                                         in this Agreement and provide for insurance and exculpation of Indemnitee as set forth
                                         in this Agreement.

 

    

     

    

 

NOW,
THEREFORE, the parties hereto agree as follows:

 

	1.	INDEMNIFICATION
                                         AND INSURANCE.
	 	 

		1.1.	The
                                         Company hereby undertakes to indemnify Indemnitee to the fullest extent permitted by
                                         applicable law and the Company's Articles of Association, as each may be amended from
                                         time to time, for any liability and expense specified in Sections 1.1.1 through 1.1.4
                                         below, imposed on Indemnitee due to or in connection with an act performed by such Indemnitee,
                                         either prior to or after the date hereof, in Indemnitee’s capacity as an Office
                                         Holder, including, without limitation, as a director, officer, employee, agent or fiduciary
                                         of the Company, any subsidiary thereof or any other corporation, collaboration, partnership,
                                         joint venture, trust or other enterprise, in which Indemnitee serves at any time at the
                                         request of the Company (the “Corporate Capacity”). The term “act
                                         performed in Indemnitee’s capacity as an Office Holder” shall include, without
                                         limitation, any act, omission and failure to act and any other circumstances relating
                                         to or arising from Indemnitee’s service in a Corporate Capacity. Notwithstanding
                                         the foregoing, in the event that the Office Holder is the beneficiary of an indemnification
                                         undertaking provided by a subsidiary of the Company or any other entity, with respect
                                         to his Corporate Capacity with such subsidiary or entity, then the indemnification obligations
                                         of the Company hereunder with respect to such Corporate Capacity shall only apply to
                                         the extent that the indemnification by such subsidiary or other entity does not actually
                                         fully cover the indemnifiable liabilities and expenses relating thereto. The following
                                         shall be hereinafter referred to as “Indemnifiable Events”:
	 	 	 

		1.1.1.	Financial
                                         liability imposed on Indemnitee in favor of any person pursuant to a court judgment,
                                         including a judgment rendered in the context of a settlement or an arbitrator’s
                                         award approved by a court. For purposes of Section 1 of this Agreement, the term “person”
                                         shall include, without limitation, a natural person, firm, partnership, joint venture,
                                         trust, company, corporation, limited liability entity, unincorporated organization, estate,
                                         government, municipality, or any political, governmental, regulatory or similar agency
                                         or body;
	 	 	 

		1.1.2.	Reasonable
                                         Expenses (as defined below) expended or incurred by Indemnitee as a result of an investigation
                                         or any proceeding instituted against the Indemnitee by an authority that is authorized
                                         to conduct an investigation or proceeding, and that was concluded without filing an indictment
                                         against the Indemnitee and without imposing on the Indemnitee a financial obligation
                                         in lieu of a criminal proceeding, or that was concluded without filing an indictment
                                         against the Indemnitee but imposing a financial obligation in lieu of a criminal proceeding
                                         in an offence that does not require proof of mens rea, or in connection with a
                                         financial sanction. In this section “conclusion of a proceeding without filing
                                         an indictment in a matter in which a criminal investigation has been instigated”
                                         and “financial liability in lieu of a criminal proceeding” shall have the
                                         meaning assigned to such terms under the Companies Law, and the term “financial
                                         sanction” shall mean such term as referred to in Section 260(a)(1a) of the Companies
                                         Law;
	 	 	 

		1.1.3.	Reasonable
                                         Expenses incurred by or charged to Indemnitee by a court, in a proceeding instituted
                                         against him by the Company or on its behalf or by another person, or in a criminal charge
                                         from which he was acquitted or in which he was convicted of an offence that does not
                                         require proof of Mens Rea;

 

    	 	- 2 -	 

     

    

 

		1.1.4.	A
                                         financial obligation imposed upon Indemnitee and reasonable Expenses expended Indemnitee
                                         as a result of an administrative proceeding instituted against Indemnitee. Without derogating
                                         from the generality of the foregoing, such obligation or Expense will include a payment
                                         which Indemnitee is obligated to make to an injured party as set forth in Section 52(54)(a)(1)(a)
                                         of the Israeli Securities Law, 1968 – 5728 (the “Israeli Securities Law”)
                                         and Expenses that Indemnitee incurred in connection with a proceeding under Chapters
                                         H'3, H'4 or I'1 of the Securities Law; and
	 	 	 

		1.1.5.	Any
                                         other event, occurrence, matter or circumstances under any law with respect to which
                                         the Company may, or will be able to, indemnify an Office Holder (including, without limitation,
                                         in accordance with Section 56h(b)(1) of the Israeli Securities Law, if applicable, and
                                         Section 50P(b)(2) of the Israeli Restrictive Trade Practices Law, 5758-1988 (the “RTP
                                         Law”)).

 

For
the purpose of this Agreement, “Expenses” shall include, without limitation, attorneys’ fees and all
other costs, expenses and obligations paid or incurred by Indemnitee in connection with investigating, defending, being a witness
in or participating in (including on appeal), or preparing to defend, be a witness in or participate in any claim, action, suit,
proceeding, alternative dispute resolution mechanism, hearing, inquiry or investigation relating to any matter for which indemnification
hereunder may be provided, and costs and expenses paid or incurred by Indemnitee in successfully enforcing this Agreement. Expenses
shall be considered paid or incurred by Indemnitee at such time as Indemnitee is required to pay or incur such cost or expenses,
including upon receipt of an invoice or payment demand. The Company shall pay the Expenses in accordance with the provisions of
Section 1.3.

 

		1.2.	Notwithstanding
                                         anything herein to the contrary, the Company’s undertaking to indemnify the Indemnitee
                                         in advance under Section 1.1.1 shall only be with respect to events described in Exhibit
                                         A hereto. The Board of Directors of the Company (the “Board”)
                                         has determined that the categories of events listed in Exhibit A are likely to occur
                                         in light of the operations of the Company. The maximum amount of indemnification payable
                                         by the Company under Section 1.1.1 of this Agreement with respect to all persons with
                                         respect to whom the Company undertook to indemnify under agreements similar to this Agreement
                                         (the “Indemnifiable Persons”), for all events described in Exhibit
                                         A shall be as set forth in Exhibit A hereto (the “Limit Amount”).
                                         If the Limit Amount is insufficient to cover all the indemnity amounts payable with respect
                                         to all Indemnifiable Persons, then such amount shall be allocated to such Indemnifiable
                                         Persons pro rata according to the percentage of their culpability, as finally determined
                                         by a court in the relevant claim, or, absent such determination or in the event such
                                         persons are parties to different claims, based on an equal pro rata allocation among
                                         such Indemnifiable Persons. The Limit Amount payable by the Company as described in Exhibit
                                         A is deemed by the Company to be reasonable in light of the circumstances. The indemnification
                                         provided under Section 1.1.1 herein shall not be subject to the limitations imposed by
                                         this Section 1.2 and Exhibit A if and to the extent such limits are no longer required
                                         by the Companies Law.

 

    	 	- 3 -	 

     

    

 

		1.3.	If
                                         so requested by Indemnitee, and subject to the Company’s repayment and reimbursements
                                         right set forth in Sections 3 and 5 below, the Company shall pay amounts to cover Indemnitee’s
                                         Expenses with respect to which Indemnitee is entitled to be indemnified under Section
                                         1.1 above, as and when incurred. The payments of such amounts shall be made by the Company
                                         directly to the Indemnitee’s legal and other advisors, as soon as practicable,
                                         but in any event no later than fifteen (15) days after written demand by such Indemnitee
                                         therefor to the Company, and any such payment shall be deemed to constitute indemnification
                                         hereunder. All amounts paid as indemnification hereunder shall be grossed-up to cover
                                         any tax payment that Indemnitee may be required to make if the indemnification payments
                                         are taxable, subject to the Limit Amount if required by applicable law. As part of the
                                         aforementioned undertaking, the Company will make available to Indemnitee any security
                                         or guarantee that Indemnitee may be required to post in accordance with an interim decision
                                         given by a court, governmental or administrative body, or an arbitrator, including for
                                         the purpose of substituting liens imposed on Indemnitee’s assets.
	 	 	 

		1.4.	The
                                         Company’s obligation to indemnify Indemnitee and advance Expenses in accordance
                                         with this Agreement shall be for such period as Indemnitee shall be subject to any actual,
                                         possible or threatened claim, action, suit, demand or proceeding or any inquiry or investigation,
                                         whether civil, criminal or investigative, arising out of the Indemnitee’s service
                                         in the Corporate Capacity as described in Section 1.1 above, whether or not Indemnitee
                                         is still serving in such position (the “Indemnification Period).
	 	 	 

		1.5.	The
                                         Company undertakes that, subject to the mandatory limitations under applicable law, as
                                         long as it may be obligated to provide indemnification and advance Expenses under this
                                         Agreement, the Company will purchase and maintain in effect directors and officers liability
                                         insurance, which will include coverage for the benefit of the Indemnitee, providing coverage
                                         in amounts as reasonably determined by the Board; provided that, the Company shall have
                                         no obligation to obtain or maintain directors and officers insurance policy if the Company
                                         determines in good faith that such insurance is not reasonably available, the premium
                                         costs for such insurance are disproportionate to the amount of coverage provided, or
                                         the coverage provided by such insurance is so limited by exclusions that it provides
                                         an insufficient benefit. The Company hereby undertakes to notify the Indemnitee 30 days
                                         prior to the expiration or termination of the directors and officers’ liability
                                         insurance.
	 	 	 

		1.6.	The
                                         Company undertakes to give prompt written notice of the commencement of any claim hereunder
                                         to the insurers in accordance with the procedures set forth in each of the policies.
                                         The Company shall thereafter diligently take all actions reasonably necessary under the
                                         circumstances to cause such insurers to pay, on behalf of Indemnitee, all amounts payable
                                         as a result of such action, suit, proceeding, inquiry or investigation in accordance
                                         with the terms of such policies. The above shall not derogate from Company’s authority
                                         to freely negotiate or reach any compromise with the insurer which is reasonable at the
                                         Company’s sole discretion provided that the Company shall act in good faith and
                                         in a diligent manner.
	 	 	 

		1.7.	In
                                         making a determination with respect to entitlement to indemnification hereunder, the
                                         person or persons or entity making such determination shall presume that Indemnitee is
                                         entitled to indemnification under this Agreement if Indemnitee has requested it, and
                                         the Company shall have the burden of proof to overcome that presumption in connection
                                         with the making of any determination contrary to that presumption.

 

    	 	- 4 -	 

     

    

 

	2.	SPECIFIC
                                         LIMITATIONS ON INDEMNIFICATION.

 

Notwithstanding
anything to the contrary in this Agreement, the Company shall not indemnify or advance Expenses to Indemnitee with respect to
(i) any act, event or circumstance with respect to which it is prohibited to do so under applicable law, or (ii) a counter claim
made by the Company or in its name in connection with a claim against the Company filed by the Indemnitee.

 

	3.	REPAYMENT
                                         OF EXPENSES.
	 	 

		3.1.	In
                                         the event that the Company provides or is required to provide indemnification with respect
                                         to Expenses hereunder and at any time thereafter the Company determines, based on advice
                                         from its legal counsel, that the Indemnitee was not entitled to such payments, the amounts
                                         so indemnified by the Company will be promptly repaid by Indemnitee, unless the Indemnitee
                                         disputes the Company’s determination, in which case the Indemnitee’s obligation
                                         to repay to the Company shall be postponed until such dispute is resolved by a court
                                         of competent jurisdiction in a final and non-appealable order.
	 	 	 

		3.2.	Indemnitee’s
                                         obligation to repay the Company for any Expenses or other sums paid hereunder shall be
                                         deemed as a loan given to Indemnitee by the Company subject to the minimum interest rate
                                         prescribed by Section 3(9) of the Income Tax Ordinance [New Version], 1961, or any other
                                         legislation replacing it, which is not considered a taxable benefit.
	 	 	 

	4.	SUBROGATION.

 

In
the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights
of recovery of Indemnitee, who shall execute all documents required and shall do everything that may be necessary to secure such
rights, including the execution of such documents necessary to enable the Company effectively to bring suit to enforce such rights.

 

	5.	REIMBURSEMENT.

 

The
Company shall not be liable under this Agreement to make any payment in connection with any Indemnifiable Event to the extent
Indemnitee has otherwise actually received payment under any insurance policy or otherwise (without any obligation of Indemnitee
to repay any such amount), of the amounts otherwise indemnifiable hereunder. Any amounts paid to Indemnitee under such insurance
policy or otherwise after the Company has indemnified Indemnitee for such liability or Expense shall be repaid to the Company
as soon as practical upon receipt by Indemnitee.

 

    	 	- 5 -	 

     

    

 

The
Company hereby acknowledges that the Indemnitee has now or may have in the future certain rights to indemnification, advancement
of expenses and/or insurance provided by third parties (the “Third Party Indemnitor”), and the Company hereby
agrees (a) that the Company is the indemnitor of first resort (i.e., its obligations to the Indemnitee are primary and any obligation
of any Third Party Indemnitor to advance expenses or to provide indemnification for the same expenses or liabilities incurred
by the Indemnitee are secondary), (b) it shall be required to advance the full amount of expenses incurred by the Indemnitee and
shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement to the fullest
extent legally permitted and as required by the terms of this Agreement and/or the Articles of Association of the Company
(or any other agreement between the Company and the Indemnitee), without regard to any rights the Indemnitee may have against
the Third Party Indemnitors, and (c) that it irrevocably waives, relinquishes and releases any Third Party Indemnitor from any
and all claims against any Third Party Indemnitor for contribution, subrogation or any other recovery of any kind of respect of
the subject matters of this Indemnification Agreement. Without altering or expanding any of the Company's indemnification obligations
hereunder, the Company further agrees that no advancement or payment by any Third Party Indemnitor on the Indemnitee 's behalf
with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the foregoing and any
Third Party Indemnitor shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to
all of the rights of recovery of the Indemnitee against the Company. The Company and the Indemnitee agree that the Third Party
Indemnitors are express third party beneficiaries of the terms of this Section 5.

 

	6.	EFFECTIVENESS.

 

The
Company represents and warrants that this Agreement is valid, binding and enforceable in accordance with its terms and was duly
adopted and approved by the Company, and shall be in full force and effect immediately upon its execution and shall continue to
be in full force for the duration of the Indemnification Period.

 

	7.	NOTIFICATION
                                         AND DEFENSE OF CLAIM.

 

Indemnitee
shall notify the Company of the commencement of any action, suit or proceeding, and of the receipt of any notice or threat that
any such legal proceeding has been or shall or may be initiated against Indemnitee (including any proceedings by or against the
Company and any subsidiary thereof), promptly upon Indemnitee first becoming so aware; but the omission to so notify the Company
will not relieve the Company from any liability which it may have to Indemnitee under this Agreement unless and to the extent
that such failure to provide notice materially i the Company’s ability to defend such action. Notice to the Company shall
be directed to the Chief Executive Officer or Chief Financial Officer of the Company at the address shown in the preamble to this
Agreement (or such other address as the Company shall designate in writing to Indemnitee). With respect to any such action, suit
or proceeding as to which Indemnitee notifies the Company of the commencement thereof and without derogating from Sections 1.1
and 2:

 

		7.1.	The
                                         Company will be entitled to participate therein at its own expense.
	 	 	 

		7.2.	Except
                                         as otherwise provided below, the Company, alone or jointly with any other indemnifying
                                         party similarly notified, will be entitled to assume the defense thereof, with counsel
                                         selected by the Company. Indemnitee shall have the right to employ his or her own counsel
                                         in such action, suit or proceeding, but the fees and expenses of such counsel incurred
                                         after notice from the Company of its assumption of the defense thereof shall be at the
                                         expense of Indemnitee, unless: (i) the employment of counsel by Indemnitee has been
                                         authorized in writing by the Company; (ii) the Company shall have, in good faith, reasonably
                                         concluded that there may be a conflict of interest under the law and rules of attorney
                                         professional conduct applicable to such claim between the Company and Indemnitee in the
                                         conduct of the defense of such action; or (iii) the Company has not in fact employed
                                         counsel to assume the defense of such action, in which cases the reasonable fees and
                                         expenses of counsel shall be at the expense of the Company. The Company shall not be
                                         entitled to assume the defense of any action, suit or proceeding brought by or on behalf
                                         of the Company or as to which the Company shall have reached the conclusion specified
                                         in (ii) above.

 

    	 	- 6 -	 

     

    

 

		7.3.	The
                                         Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts
                                         or expenses paid in connection with a settlement of any action, claim or otherwise, effected
                                         without the Company’s prior written consent.
	 	 	 

		7.4.	The
                                         Company shall have the right to conduct the defense as it sees fit in its sole discretion
                                         (provided that the Company shall conduct the defense in good faith and in a diligent
                                         manner and that the Company and its counsel shall keep the indemnitee reasonably notified
                                         on a regular basis of all events in the action), including the right to settle or compromise
                                         any claim or to consent to the entry of any judgment against Indemnitee without the consent
                                         of the Indemnitee, provided that, the amount of such settlement, compromise or judgment
                                         does not exceed the Limit Amount (if applicable) and is fully indemnifiable pursuant
                                         to this Agreement (subject to Section 1.2 of this Agreement) and/or applicable law, and
                                         any such settlement, compromise or judgment does not impose any penalty or limitation
                                         on Indemnitee without the Indemnitee’s prior written consent. The Indemnitee’s
                                         consent shall not be required if the settlement includes a complete release of Indemnitee,
                                         does not contain any admission of wrong-doing by Indemnitee, and includes monetary sanctions
                                         only as provided above. In the case of criminal proceedings the Company and/or its legal
                                         counsel will not have the right to plead guilty or agree to a plea-bargain in the Indemnitee’s
                                         name without the Indemnitee’s prior written consent. Neither the Company nor Indemnitee
                                         will unreasonably withhold or delay their consent to any proposed settlement.
	 	 	 

		7.5.	Indemnitee
                                         shall fully cooperate with the Company and shall give the Company all information and
                                         access to documents, files and to his advisors and representatives as shall be within
                                         Indemnitee’s power, in every reasonable way as may be required by the Company with
                                         respect to any claim which is the subject matter of this Agreement and in the defense
                                         of other claims asserted against the Company (other than claims asserted by Indemnitee),
                                         provided that the Company shall cover all expenses, costs and fees incidental thereto
                                         such that the Indemnitee will not be required to pay or bear such expenses, costs and
                                         fees.
	 	 	 

	8.	EXCULPATION.

 

Subject
to the provisions of the Companies Law, the Company hereby releases, in advance, the Office Holder from liability to the Company
for any damage that arises from the breach of the Office Holder’s duty of care to the Company (within the meaning of such
terms under Sections 252 and 253 of the Companies Law), other than breach of the duty of care towards the Company in a distribution
(as such term is defined in the Companies Law).

 

	9.	NON-EXCLUSIVITY.

 

The
rights of the Indemnitee hereunder shall not be deemed exclusive of any other rights Indemnitee may have under the Company’s
Articles of Association, applicable law or otherwise, and to the extent that during the Indemnification Period the indemnification
rights of the then serving Indemnitees are more favorable to such Indemnitees than the indemnification rights provided under this
Agreement, Indemnitee shall be entitled to the full benefits of such more favorable indemnification rights to the extent permitted
by law.

 

	10.	PARTIAL
                                         INDEMNIFICATION.

 

If
Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of the Expenses,
judgments, fines or penalties actually or reasonably incurred by Indemnitee in connection with any proceedings, but not, however,
for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such Expenses, judgments,
fines or penalties to which Indemnitee is entitled under any provision of this Agreement. Subject to the provisions of Section
4 above, any amount received by Indemnitee (under any insurance policy or otherwise) shall not reduce the Limit Amount hereunder
and shall not derogate from the Company’s obligation to indemnify the Indemnitee in accordance with the provisions of this
Agreement up to the Limit Amount, as set forth in Section 1.2.

 

    	 	- 7 -	 

     

    

 

	11.	BINDING
                                         EFFECT.

 

This
Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors
and permitted assigns. In the event of a merger or consolidation of the Company or a transfer or disposition of all or substantially
all of the business or assets of the Company, the Indemnitee shall be entitled to the same indemnification and insurance provisions
as the most favorable indemnification and insurance provisions afforded to the then-serving Office Holders of the Company. In
the event that in connection with such transaction the Company purchases a directors and officers’ “tail” or
“run-off” policy for the benefit of its then serving Office Holders, then such policy shall cover Indemnitee and such
coverage shall be deemed to be in satisfaction of the insurance requirements under this Agreement. This Agreement shall continue
in effect during the Indemnification Period regardless of whether Indemnitee continues to serve in a Corporate Capacity.

 

Any
amendment to the Companies Law, the Israeli Securities Law, the RTP Law or other applicable law adversely affecting the right
of the Indemnitee to be indemnified, insured or released pursuant hereto shall be prospective in effect, and shall not affect
the Company’s obligation or ability to indemnify or insure the Indemnitee for any act or omission occurring prior to such
amendment, unless otherwise provided by applicable law.

 

	12.	SEVERABILITY.

 

The
provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect
the validity or enforceability of the other provisions hereof. If any provision of this Agreement, or the application thereof
or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order
to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b)
the remainder of this Agreement and the application of such provision or circumstances shall not be affected by such invalidity
or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or
the application thereof, in any other jurisdiction.

 

    	 	- 8 -	 

     

    

 

	13.	NOTICE.

 

All
notices and other communications pursuant to this Agreement shall be in writing and shall be deemed provided if delivered personally,
telecopied, sent by electronic facsimile, email, reputable overnight courier or mailed by registered or certified mail (return
receipt requested), postage prepaid, to the parties at the addresses shown in the preamble to this Agreement, or to such other
address as the party to whom notice is to be given may have furnished to the other party hereto in writing in accordance herewith.
Any such notice or communication shall be deemed to have been delivered and received (i) in the case of personal delivery, on
the date of such delivery, (ii) in the case of telecopier or an electronic facsimile or email, one business day after the date
of transmission if confirmation of receipt is received, (iii) in the case of a reputable overnight courier, three business days
after deposit with such reputable overnight courier service, and (iv) in the case of mailing, on the seventh business day following
that on which the mail containing such communication is posted.

 

	14.	GOVERNING
                                         LAW; JURISDICTION.

 

This
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Israel, without giving effect
to the conflicts of law provisions of those laws. The Company and Indemnitee each hereby irrevocably consent to the exclusive
jurisdiction and venue of the courts of Tel Aviv, Israel for all purposes in connection with any action or proceeding which arises
out of or relates to this Agreement.

 

	15.	ENTIRE
                                         AGREEMENT AND TERMINATION.

 

This
Agreement represents the entire agreement between the parties and supersedes any other agreements, contracts or understandings
between the parties, whether written or oral, with respect to the subject matter of this Agreement. For the avoidance of doubt,
it is hereby clarified that nothing contained herein derogates from the Company’s right in its sole discretion, subject
to applicable law and the Articles of Association of the Company, to indemnify Indemnitee post factum for any amounts which Indemnitee
may be obligated to pay.

 

	16.	NO
                                         MODIFICATION AND NO WAIVER.

 

No
supplement, modification or amendment, termination or cancellation of this Agreement shall be binding unless executed in writing
by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver
of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. Any waiver shall
be in writing. The Company hereby undertakes not to amend its Articles of Association in a manner which will adversely affect
the provisions of this Agreement.

 

	17.	ASSIGNMENTS;
                                         NO THIRD PARTY RIGHTS

 

Neither
party hereto may assign any of its rights or obligations hereunder except with the express prior written consent of the other
party. Nothing herein shall be deemed to create or imply an obligation for the benefit of a third party. Without limitation of
the foregoing, nothing herein shall be deemed to create any right of any insurer that provides directors and officers’ liability
insurance, to claim, on behalf of Indemnitee, any rights hereunder.

 

	18.	INTERPRETATION;
                                         DEFINITIONS.

 

The
obligations of the Company as provided hereunder shall be interpreted broadly and in a manner that shall facilitate its execution,
to the extent permitted by law, and for the purposes for which it was intended.

 

    	 	- 9 -	 

     

    

 

Unless
the context shall otherwise require: words in the singular shall also include the plural, and vice versa; any pronoun shall include
the corresponding masculine, feminine and neuter forms; the words “include”, “includes” and “including”
shall be deemed to be followed by the phrase “without limitation”; the words “herein”, “hereof”
and “hereunder” and words of similar import refer to this Agreement in its entirety and not to any part hereof; all
references herein to Sections or clauses shall be deemed references to Sections or clauses of this Agreement; any references to
any agreement or other instrument or law, statute or regulation are to it as amended, supplemented or restated, from time to time
(and, in the case of any law, to any successor provisions or re-enactment or modification thereof being in force at the time);
any reference to “law” shall include any supranational, national, federal, state, local, or foreign statute or law
and all rules and regulations promulgated thereunder; any reference to a “day” or a number of “days” (without
any explicit reference otherwise, such as to business days) shall be interpreted as a reference to a calendar day or number of
calendar days; reference to month or year means according to the Gregorian calendar; reference to a “company”, “corporate
body” or “entity” shall include a, partnership, firm, company, corporation, limited liability company, association,
joint venture, trust, unincorporated organization, estate, or a government municipality or any political, governmental, regulatory
or similar agency or body, and reference to a “person” shall mean any of the foregoing or a natural person.

 

	19.	COUNTERPARTS

 

This
Agreement may be executed in any number of counterparts, each of which shall be deemed an original and enforceable against the
parties actually executing such counterpart, and all of which together shall constitute one and the same instrument; it being
understood that parties need not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise)
by facsimile or by electronic delivery in pdf format shall be sufficient to bind the parties to the terms and conditions of this
Agreement, as an original.

 

[SIGNATURE
PAGE TO FOLLOW]

 

    	 	- 10 -	 

     

    

 

IN
WITNESS WHEREOF, the parties, each acting under due and proper authority, have executed this Indemnification Agreement as
of the date first mentioned above, in one or more counterparts.

 

	MaxQ
    AI Ltd.	 
	 	 
	By:	 	 
	 	 	 
	Name
    and title:	 	 

 

	Indemnitee:	 
	 	 
	Name:	 	 
	 	 	 
	Signature:	 	 
	 	 	 
	Address:	 	 

 

 

    	 	- 11 -	 

     

    

 

EXHIBIT
A*

 

	 	CATEGORY
    OF INDEMNIFIABLE EVENT	 	LIMIT
AMOUNT PER EACH SPECIFIC EVENT WITHIN THIS CATEGORY OF EVENTS

	 	 	 	 
	1.1	Claims
    in connection with employment relationships with and/or by employees or consultants of the Company, and in connection with
    business relations between the Company and its employees, independent contractors, customers, suppliers and various service
    providers.	 	The
    greater of (a) twenty-five percent (25%) of the Company’s total shareholders’ equity according to the Company’s
    most recent audited or reviewed financial statements as of the time of the actual payment of indemnification, (b) $10 million,
    and (c) in connection with or arising out of a public offering of the Company’s securities, the aggregate amount of
    proceeds from the sale by the Company and/or any shareholder of Company’s securities in such offering (the “Maximum
    Amount”).
	 	 	 	 
	2.	Negotiations,
    execution, delivery and performance of agreements of any kind or nature, anti-competitive acts, acts of commercial wrongdoing,
    approval of corporate actions including the approval of the acts of the Company’s management, their guidance and their
    supervision, actions concerning the approval of transactions with Office Holders or shareholders, including controlling persons
    and claims of failure to exercise business judgment and a reasonable level of proficiency, expertise and care with respect
    to the Company’s business. 	 	The
    Maximum Amount
	 	 	 	 
	3.	Violation,
    infringement, misappropriation, dilution and other misuse of copyrights, patents, designs, trade secrets and any other intellectual
    property rights, acts in connection with the registration, assertion or protection of rights to intellectual property and
    the defense of claims related to intellectual property, breach of confidentiality obligations, acts in regard of invasion
    of privacy including with respect to databases or personal information, acts in connection with slander and defamation, and
    claims in connection with publishing or providing any information, including any filings with any governmental authorities,
    whether or not required under any applicable laws.	 	The
    Maximum Amount

 

    	 	- 12 -	 

     

    

 

	4.	Violations
    of securities laws of any jurisdiction, including without limitation, claims under the U.S. Securities Act of 1933, as amended
    from time to time, or the U.S. Exchange Act of 1934, as amended from time to time, or under the Israeli Securities Law, as
    amended from time to time, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange
    disclosure or other rules and any other claims relating to relationships with investors, debt holders, shareholders and the
    investment community and any claims related to the Sarbanes-Oxley Act of 2002, as amended from time to time; claims relating
    to or arising out of financing arrangements, any breach of financial covenants or other obligations towards lenders or debt
    holders of the Company, class actions, violations of laws requiring the Company to obtain regulatory and governmental licenses,
    permits and authorizations in any jurisdiction; actions taken in connection with the issuance, purchase, holding or disposition
    of any type of securities of Company, including, without limitation, the grant of options to purchase any of the same or any
    offering of the Company’s securities to private investors or to the public, and listing of such securities, or the offer
    by the Company to purchase securities from the public or from private investors or other holders, and any undertakings, representations,
    warranties and other obligations related to any such offering, listing or offer or to the Company’s status as a public
    company or as an issuer of securities.	 	The
    Maximum Amount
	 	 	 	 
	5.	Liabilities
    arising in connection with the conduct of clinical trials, testing, development or manufacturing of any products or services
    developed, distributed, rendered, sold, provided, licensed or marketed by the Company, and any actions in connection with
    the distribution, provision, sale, marketing, license or use of such products or services, including without limitation in
    connection with professional liability and product liability claims.	 	The
    Maximum Amount
	 	 	 	 
	6.	The
    offering of securities by the Company to the public and/or to private investors or the offer by the Company to purchase securities
    from the public and/or from private investors or other holders pursuant to a prospectus, agreements, notices, reports, tenders
    and/or other proceedings.	 	The
    Maximum Amount
	 	 	 	 
	7.	Events
    in connection with change in ownership or in the structure of the Company, its reorganization, dissolution, or any decision
    concerning any of the foregoing, including but not limited to, merger, sale or acquisition of assets, division, change in
    capital. 	 	The
    Maximum Amount
	 	 	 	 
	8.	Any
    claim or demand made in connection with any transaction not in the ordinary course of business of the Company, including the
    sale, lease or purchase of any assets or business.	 	The
    Maximum Amount

 

    	 	- 13 -	 

     

    

 

	9.	Any
    claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to business or personal
    property or any other type of damage through any act or omission attributed to the Company, or its employees, agents or other
    persons acting or allegedly acting on its behalf, including, without limitation, failure to make proper safety arrangements
    for the Company or its employees and liabilities arising from any accidental or continuous damage or harm to the Company’s
    employees, its contractors, its guests and visitors as a result of an accidental or continuous event, or employment conditions,
    permanent or temporary, in the Company’s offices.	 	The
    Maximum Amount
	 	 	 	 
	10.	Any
    claim or demand made directly or indirectly in connection with complete or partial failure, by the Company or its directors,
    officers and employees, to pay, report, keep applicable records or otherwise, of any foreign, federal, state, county, local,
    municipal or city taxes or other compulsory payments of any nature whatsoever, including, without limitation, income, sales,
    use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property,
    capital stock, social security, unemployment, disability, payroll or employee withholding or other withholding, including
    any interest, penalty or addition thereto, whether disputed or not.	 	The
    Maximum Amount
	 	 	 	 
	11.	Any
    administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand letters, directives, claims,
    liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging
    potential responsibility or liability (including potential responsibility or liability for costs of enforcement investigation,
    cleanup, governmental response, removal or remediation, for natural resources damages, property damage, personal injuries
    or penalties or for contribution, indemnification, cost recovery, compensation or injunctive relief) arising out of, based
    on or related to (a) the presence of, release, spill, emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching
    or migration into the environment (each a “Release”) or threatened Release of, or exposure to, any hazardous,
    toxic, explosive or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos
    or asbestos-containing material, polychlorinated biphenyls (“PCBs”) or PCB-containing materials or equipment,
    radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any environmental
    law, at any location, whether or not owned, operated, leased or managed by the Company or any of its subsidiaries, or (b)
    circumstances forming the basis of any violation of any environmental law or environmental permit, license, registration or
    other authorization required under applicable environmental law or public health law.	 	The
    Maximum Amount
	 	 	 	 
	12.	Any
    administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens,
    investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging the
    failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable
    to the Company or any of its businesses, assets or operations, or the terms and conditions of any operating certificate or
    licensing agreement.	 	The
    Maximum Amount

 

    	 	- 14 -	 

     

    

 

	13.	Participation
    and/or non-participation at the Company’s Board meetings, bona fide expression of opinion and/or voting and/or abstention
    from voting at the Company’s Board meetings.	 	The
    Maximum Amount
	 	 	 	 
	14.	Review
    and approval of the Company’s financial statements, including any action, consent or approval related to or arising
    from the foregoing, including, without limitations, execution of certificates for the benefit of third parties related to
    the financial statements. 	 	The
    Maximum Amount
	 	 	 	 
	15.	Violation
    of laws, rules or regulations requiring the Company to obtain regulatory and governmental licenses, permits and authorizations
    (including without limitation relating to export, import, encryption, antitrust or competition authorities) or laws related
    to any governmental grants in any jurisdiction. 	 	The
    Maximum Amount
	 	 	 	 
	16.	Resolutions
    and/or actions relating to investments in the Company and/or its subsidiaries and/or affiliated companies and/or the purchase
    and sale of assets, including the purchase or sale of companies and/or businesses, and/or investment in corporate or other
    entities and/or investments in traded securities and/or any other form of investment. 	 	The
    Maximum Amount
	 	 	 	 
	17.	Liabilities
    arising out of advertising, including misrepresentations regarding the Company's products or services and unlawful distribution
    of emails.	 	The
    Maximum Amount
	 	 	 	 
	18.	An
    announcement or statement, including a position taken or an opinion or representation made in good faith by the Office Holder
    in the course of his duties or in conjunction with his duties, whether in public or in private, including during a meeting
    of the Board of Directors of the Company or any of the committees thereof.	 	The
    Maximum Amount
	 	 	 	 
	19.	Management
    of the Company’s bank accounts, including money management, foreign currency deposits, securities, loans and credit
    facilities, credit cards, bank guarantees, letters of credit, consultation agreements concerning investments including with
    portfolio managers, hedging transactions, options, futures, and the like.	 	The
    Maximum Amount
	 	 	 	 
	20.	Any
    action or decision in relation to protection of work safety and/or working conditions, including with respect to provisions
    of the law, procedures or standards as applicable in or outside of Israel with relating to protection of work safety, pertaining,
    inter alia, to contamination, health protection, production processes, distribution, use, treatment, storage and transportation
    of certain materials, including in connection with corporal damage, property and environmental damages.	 	The
    Maximum Amount

 

    	 	- 15 -	 

     

    

 

	21.	Any
    liability arising under any administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand
    letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation of Section 50P(b)(2)
    of the Israeli Restrictive Trade Practices Law, 5758-1988.	 	The
    Maximum Amount
	 	 	 	 
	22.	All
    actions, consents and approvals relating to a distribution of dividends, in cash or otherwise.	 	The
    Maximum Amount
	 	 	 	 
	 	Aggregate
    Limit Amount for all events together.	 	The
    Maximum Amount
	 	 	 	 

	*	Any
                                         reference in this Exhibit A to the Company shall include the Company and any entity in
                                         which the Indemnitee serves in a Corporate Capacity.

 

 -
16 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]